OptimizeRx Corporation

OptimizeRx Corporation

OPRX·NASDAQ

$5.53

+11%
HealthcareMedical - Healthcare Information Services

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.

At a Glance

Live Snapshot
Market Cap$103.77M
EPS0.2800
P/E Ratio19.75
Earnings Date08/06/2026

oprx

Cost of Revenue

Last Annual Value

40.16M

3-Year CAGR

20%

5-Year CAGR

16%

10-Year CAGR

27%

OptimizeRx Corporation

OptimizeRx Corporation Competitors Analysis of Cost of Revenue

OPRX · NASDAQ
CompanyCost of Revenue
CAGR 3Y
CAGR 5Y
CAGR 10Y
40.16M
12.0%9.4%28.0% 
29.57M
-19.7%-16.4%-0.4%
58.25M
7.0%7.4%N/A
RXST logo
RxSight, Inc.
NASDAQ:RXST
31.47M
-3.8%11.7%N/A
NPCE logo
NeuroPace, Inc.
NASDAQ:NPCE
22.77M
9.6%14.1%N/A
SRDX logo
Surmodics, Inc.
NASDAQ:SRDX
33.03M
-22.7%-12.4%1.2%
433.24M
17.9%21.7%N/A
3.25M
N/A-12.1%-1.9%
NAKA logo
Nakamoto Inc.
NASDAQ:NAKA
11.09M
40.1%47.5%N/A
4.76M
-12.0%-4.9%9.8%
59.99M
2.3%2.8%2.8%
OptimizeRx Corporation

OptimizeRx Corporation Fair Value Envelope

OPRX · NASDAQ

Our analysis suggests that OPRX has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $5.53, this represents a potential HIDDEN relative to our calculated worth for OptimizeRx Corporation.

Intrinsic Value
Current Price: $5.53